F X Bosch

Summary

Country: Spain

Publications

  1. pmc Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population
    M Paz Cañadas
    Departament de Biologia Molecular, General Lab, Barcelona, Spain
    J Clin Microbiol 42:1330-2. 2004
  2. pmc HPV and cervical cancer: screening or vaccination?
    F X Bosch
    Cancer Epidemiology and Registration Unit, IDIBELL, Institut Catala d Oncologia, L Hospitalet del Llobregat, Barcelona, Spain
    Br J Cancer 98:15-21. 2008
  3. doi request reprint Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain
    Luis M Puig-Tintore
    Gynecologic Oncology, Hospital Clinic, University of Barcelona, Catalonia, Spain
    J Low Genit Tract Dis 12:82-9. 2008
  4. pmc Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries
    K S Louie
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Hospitalet del Llobregat Barcelona, Barcelona, Spain
    Br J Cancer 100:1191-7. 2009
  5. pmc Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
    Beatriz Serrano
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL, Institut Català d Oncologia ICO Catalan Institute of Oncology, Gran Via de L Hospitalet, 199 203, L Hospitalet de Llobregat, Barcelona, Spain
    Infect Agent Cancer 7:38. 2012
  6. pmc Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study
    Ginesa Albero
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, Catalan Institute of Oncology ICO, L Hospitalet de Llobregat 08908, Barcelona, Spain
    BMC Infect Dis 13:18. 2013
  7. pmc Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
    Esther Roura
    Cancer Epidemiology Research Program, Institut Català d Oncologia IDIBELL, CIBER ESP, RTICC, L Hospitalet de Llobregat, Barcelona, Catalonia, Spain
    BMC Infect Dis 12:145. 2012
  8. doi request reprint Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases
    F Xavier Bosch
    Cancer Epidemiology Research Program, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Vaccine 30:F1-11. 2012
  9. pmc Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain
    Raquel Ibanez
    Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Av, Gran Via, 199 203L Hospitalet de Llobregat, 08907 Barcelona, Spain
    BMC Infect Dis 12:25. 2012
  10. pmc Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array
    Jose M Godínez
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL, Catalan Institute of Oncology ICO, Gran Via 199 203, L Hospitalet de Llobregat 08907, Barcelona, Spain
    Infect Agent Cancer 6:23. 2011

Detail Information

Publications63

  1. pmc Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population
    M Paz Cañadas
    Departament de Biologia Molecular, General Lab, Barcelona, Spain
    J Clin Microbiol 42:1330-2. 2004
    ..HPV was found in 43.6% of the women, and its prevalence at genital sites was similar. Prevalence was highest among women aged 20 years or younger but declined thereafter in specimens from all anogenital sites...
  2. pmc HPV and cervical cancer: screening or vaccination?
    F X Bosch
    Cancer Epidemiology and Registration Unit, IDIBELL, Institut Catala d Oncologia, L Hospitalet del Llobregat, Barcelona, Spain
    Br J Cancer 98:15-21. 2008
    ..Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition...
  3. doi request reprint Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain
    Luis M Puig-Tintore
    Gynecologic Oncology, Hospital Clinic, University of Barcelona, Catalonia, Spain
    J Low Genit Tract Dis 12:82-9. 2008
    ..To quantify the coverage and monitor the factors associated with opportunistic cervical cytological screening in Spain...
  4. pmc Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries
    K S Louie
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Hospitalet del Llobregat Barcelona, Barcelona, Spain
    Br J Cancer 100:1191-7. 2009
    ..These data confirm AFSI and AFB as risk factors for ICC in eight developing countries, but any independent effects of these two events could not be distinguished...
  5. pmc Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
    Beatriz Serrano
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL, Institut Català d Oncologia ICO Catalan Institute of Oncology, Gran Via de L Hospitalet, 199 203, L Hospitalet de Llobregat, Barcelona, Spain
    Infect Agent Cancer 7:38. 2012
    ..abstract:..
  6. pmc Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study
    Ginesa Albero
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, Catalan Institute of Oncology ICO, L Hospitalet de Llobregat 08908, Barcelona, Spain
    BMC Infect Dis 13:18. 2013
    ..The purpose of this study was to assess the association between MC and genital HPV infection in men in a large multinational study...
  7. pmc Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
    Esther Roura
    Cancer Epidemiology Research Program, Institut Català d Oncologia IDIBELL, CIBER ESP, RTICC, L Hospitalet de Llobregat, Barcelona, Catalonia, Spain
    BMC Infect Dis 12:145. 2012
    ..The aim of the current study was to investigate socio-demographic, lifestyle, and medical factors for potential associations with cervical HPV infection in women undergoing cervical cancer screening in Spain...
  8. doi request reprint Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases
    F Xavier Bosch
    Cancer Epidemiology Research Program, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Vaccine 30:F1-11. 2012
    ..This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
  9. pmc Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain
    Raquel Ibanez
    Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Av, Gran Via, 199 203L Hospitalet de Llobregat, 08907 Barcelona, Spain
    BMC Infect Dis 12:25. 2012
    ..We evaluated the implementation of the protocol and the prediction of HPV testing as a triage tool for cervical intraepithelial lesions grade two or worse (CIN2+) in women with a cytological diagnosis of ASC-US...
  10. pmc Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array
    Jose M Godínez
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL, Catalan Institute of Oncology ICO, Gran Via 199 203, L Hospitalet de Llobregat 08907, Barcelona, Spain
    Infect Agent Cancer 6:23. 2011
    ..abstract:..
  11. pmc Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain
    Xavier Castellsague
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
    BMC Infect Dis 9:74. 2009
    ..Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results...
  12. pmc Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy
    Luciano Mariani
    Regina Elena National Cancer Institute, Dept Gynecologic Oncology, Roma, Italy
    BMC Cancer 10:259. 2010
    ..Human papillomavirus (HPV) infection is now well-established as a necessary cause of invasive cervical cancer (ICC) development. Only a few studies on HPV prevalence and type-specific distribution in ICC have been conducted in Italy...
  13. doi request reprint Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia
    F Xavier Bosch
    Cancer Epidemiology Research Program CERP, Institut Català d Oncologia Catalan Institute of Oncology ICO, L Hospitalet de Llobregat Barcelona, Spain
    Vaccine 26:K1-16. 2008
    ....
  14. ncbi request reprint Preface. The field of cervical cancer prevention
    F Xavier Bosch
    Epidemiology and Cancer Registry Unit, IDIBELL, Institut Catala d Oncologia, Avenida Gran Via s n, L Hospitalet de Llobregat, Barcelona, Spain
    Vaccine 24:S3/v-vi. 2006
  15. ncbi request reprint [Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners]
    S de Sanjose
    Servicio de Epidemiología y Registro del Cáncer, Institut Catala d Oncologia, Barcelona
    Med Clin (Barc) 115:81-4. 2000
    ..The study was designed to estimate the prevalence of HPV infection and the related risk of cervical cancer among imprisoned women...
  16. pmc Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference
    F X Bosch
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    J Clin Pathol 54:163-75. 2001
    ..This leader summarises the highlights presented at the conference (the full text of the abstracts and lectures can be found at www.hpv2000.com). Relevant material in Spanish can be found at www.aepcc.org...
  17. doi request reprint Human papillomavirus prevalence and type distribution in penile carcinoma
    C Miralles-Guri
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, L Hospitalet de Ll, Barcelona, Spain
    J Clin Pathol 62:870-8. 2009
    ..HPV prevalence in penile tumours is reported to be associated to a variety of morphological changes. Its determination will provide a better estimate for HPV related cancer burden and its preventable fraction...
  18. pmc Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
    M Diaz
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Programme, Catalan Institute of Oncology ICO, Av Gran Via, s n km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Br J Cancer 99:230-8. 2008
    ....
  19. doi request reprint Differential presence of Papillomavirus variants in cervical cancer: an analysis for HPV33, HPV45 and HPV58
    J M Godínez
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Bellvitge Institute of Biomedical Research IDIBELL, Catalan Institute of Oncology ICO, Barcelona, Spain
    Infect Genet Evol 13:96-104. 2013
    ..The aim of the present work was to analyze the presence of HPV33, HPV45 and HPV58 variants in cases of cervical cancer...
  20. ncbi request reprint Epidemiology of primary liver cancer
    F X Bosch
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Semin Liver Dis 19:271-85. 1999
    ....
  21. ncbi request reprint Epidemiology of liver cancer in Europe
    F X Bosch
    L Hospitalet de Llobregat, Barcelona, Spain
    Can J Gastroenterol 14:621-30. 2000
    ....
  22. pmc The causal relation between human papillomavirus and cervical cancer
    F X Bosch
    Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Gran Via Km 2 7 s n 08907 L Hospitalet de Llobregat, 08907 Barcelona, Spain
    J Clin Pathol 55:244-65. 2002
    ..It is the right time for medical societies and public health regulators to consider this evidence and to define its preventive and clinical implications. A comprehensive review of key studies and results is presented...
  23. doi request reprint HPV vaccines and cervical cancer
    F X Bosch
    Cancer Epidemiology Research Program CERP, IDIBELL, Institut Catala d Oncologia, L Hospitalet del Llobregat, Barcelona, Spain
    Ann Oncol 19:v48-51. 2008
  24. ncbi request reprint Is viral status needed before vaccination?
    Thomas C Wright
    Department of Pathology, Columbia University, Room 16 404, P and S Building, 630 West 168th Street, New York, NY, United States
    Vaccine 26:A12-5. 2008
    ..The increase in cost and the other barriers afforded by a prior to vaccination test requirement would result in a lower coverage, the key indicator of a successful vaccination program...
  25. ncbi request reprint Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention
    Xavier Castellsague
    Institut d Investigacio Biomedica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d Oncologia L Hospitalet de Llobregat, Barcelona, Spain
    J Natl Cancer Inst 98:303-15. 2006
    ..The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear...
  26. ncbi request reprint Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 119:2677-84. 2006
    ..These differences, however, underline that great caution should be used in inferring the natural history of HPV from age-specific prevalences...
  27. ncbi request reprint Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Barcelona, Spain
    Lancet Infect Dis 7:453-9. 2007
    ..The HPV types most commonly detected are similar to those most commonly described in pre-neoplastic and cancer cases, although the relative contribution of HPV16 and HPV18 is substantially lower in cytologically normal women...
  28. ncbi request reprint The epidemiology of human papillomavirus infection and cervical cancer
    F Xavier Bosch
    Institut Catala d Oncologia, Epidemiology and Cancer Registration Unit, E 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Dis Markers 23:213-27. 2007
    ..Women exposed to the Human Immunodeficiency Virus (HIV) are at high risk for HPV infection, HPV DNA persistency and progression of HPV lesions to cervical cancer...
  29. ncbi request reprint Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention
    Xavier Castellsague
    IDIBELL, Institut Català d Oncologia ICO, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 122:1901-4. 2008
    ..The introduction of an efficacious HPV 16/18 vaccine could potentially prevent the occurrence of 72% of cervical cancer cases and up to 81% of the cases if full cross-protection against HPVs 31 and 45 is assumed...
  30. ncbi request reprint Risk factors of invasive cervical cancer in Mali
    Sine Bayo
    Institut National de Recherche en Sante Publique, Bamako, Mali
    Int J Epidemiol 31:202-9. 2002
    ..Cervical cancer is the most common cancer in women in Mali and the second commonest cause of cancer mortality...
  31. ncbi request reprint Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
    Jennifer S Smith
    International Agency for Research on Cancer, F 69372 Lyon Cedex 08, France
    J Infect Dis 185:324-31. 2002
    ..C. trachomatis infection was found to be a possible cofactor of HPV in the etiology of squamous cervical cancer, and its effect may be mediated by chronic inflammation...
  32. ncbi request reprint Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study
    Rolando Herrero
    International Agency for Research on Cancer, Lyon, France rherrero amnet co cr
    J Natl Cancer Inst 95:1772-83. 2003
    ..To investigate these associations, we conducted a multicenter case-control study of cancer of the oral cavity and oropharynx in nine countries...
  33. ncbi request reprint Cervical human papillomavirus infection in the female population in Barcelona, Spain
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Via km 2 7 E 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Sex Transm Dis 30:788-93. 2003
    ..Human papillomavirus (HPV) is a major cause of invasive cervical cancer. Identification of HPV determinants might allow for targeting of high-risk groups for cervical cancer...
  34. ncbi request reprint Epidemiology of human papillomavirus infections: new options for cervical cancer prevention
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit SERC, Catalan Institute of Oncology ICO, Hospital Duran i Reynals, Avenida Gran Via, s n km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Salud Publica Mex 45:S326-39. 2003
    ..Time is ripe for exploring in depth the clinical implications of current achievements and to devise novel strategies for the prevention of cervical cancer. This paper is available too at: http://www.insp.mx/salud/index.html...
  35. ncbi request reprint Epidemiologic classification of human papillomavirus types associated with cervical cancer
    Nubia Munoz
    International Agency for Research on Cancer, Lyons, France
    N Engl J Med 348:518-27. 2003
    ..Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed...
  36. ncbi request reprint Environmental co-factors in HPV carcinogenesis
    Xavier Castellsague
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Vias n km 2, 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Virus Res 89:191-9. 2002
    ....
  37. ncbi request reprint The viral etiology of cervical cancer
    F Xavier Bosch
    Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, Hospital Duran i Reynals, Gran Via km 2, 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Virus Res 89:183-90. 2002
    ..This is a subjective evaluation that could be guided by a careful description of the most relevant studies and findings...
  38. ncbi request reprint Cervical cancer control, priorities and new directions
    Joseph Monsonego
    EUROGIN, Paris, France
    Int J Cancer 108:329-33. 2004
    ..We report the conclusions of the Experts' Meeting at the EUROGIN 2003 conference...
  39. ncbi request reprint Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
    J Natl Cancer Inst 96:604-15. 2004
    ..We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 vaccine in a population with an organized cervical cancer screening program...
  40. ncbi request reprint Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer
    Jennifer S Smith
    Unit of Field and Intervention Studies, International Agency for Research on Cancer IARC, Lyon, France
    J Natl Cancer Inst 94:1604-13. 2002
    ..We performed a pooled analysis of seven case-control studies to examine the effect of one possible HPV cofactor, herpes simplex virus-2 (HSV-2) infection, in the etiology of invasive cervical cancer...
  41. ncbi request reprint Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners
    Xavier Castellsague
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Hospitalet de Llobregat, Barcelona, Spain
    N Engl J Med 346:1105-12. 2002
    ..It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner...
  42. ncbi request reprint Against which human papillomavirus types shall we vaccinate and screen? The international perspective
    Nubia Munoz
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:278-85. 2004
    ..The impact of modifying the number of types in the screening cocktail tests would be small and probably irrelevant for screening programs...
  43. ncbi request reprint Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study
    Nubia Munoz
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372, Cedex 08, Lyon, France
    Lancet 359:1093-101. 2002
    ..To assess the role of reproductive factors in the progression from HPV infection to cancer, we did a pooled analysis including only HPV-positive women...
  44. ncbi request reprint Human papillomavirus in cervical cancer
    F Xavier Bosch
    Servei dEpidemiologia i Registre del Càncer, Institut Català dOncologia, Av Gran Via, s n km 2 7, 08907 LHospitalet de Llobregat, Barcelona, Spain
    Curr Oncol Rep 4:175-83. 2002
    ....
  45. ncbi request reprint Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study
    Victor Moreno
    Epidemiology and Cancer Registry Service, Catalan Institute of Oncology, Hospital Duran i Reynals, L Hospitalet de Llobregat, Barcelona, Spain
    Lancet 359:1085-92. 2002
    ..We aimed to assess how use of oral contraceptives affected risk of cervical cancer in women who tested positive for HPV DNA...
  46. ncbi request reprint Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 98:155-8. 2002
    ..All PBMC samples were negative. These results suggest that in low-risk countries for KSHV, oral shedding and heterosexual contacts are potential pathways for KSHV transmission...
  47. ncbi request reprint Can screening for cervical cancer be improved, especially in developing countries?
    Anthony B Miller
    Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany
    Int J Cancer 107:337-40. 2003
  48. ncbi request reprint Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study
    Silvia de Sanjose
    Institut Catala d Oncologia, Hospitalet de LL, Barcelona, Spain
    Int J Cancer 106:588-93. 2003
    ..The contribution of these genes to early-onset breast cancer is likely to be even higher given that certain UV cases might be disease-associated...
  49. pmc Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16
    Itzel E Calleja-Macias
    Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697 3900, USA
    J Virol 79:13630-40. 2005
    ..Some had one, two, or three amino acid substitutions in these regions, which might indicate biological and pathogenic diversity between the variants of each HPV type...
  50. ncbi request reprint Epidemiology of hepatocellular carcinoma
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit, IDIBELL, Institut Catala d Oncologia, Avda Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Clin Liver Dis 9:191-211, v. 2005
    ..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...
  51. ncbi request reprint Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18
    Jose C Prado
    Ludwig Institute for Cancer Research, Sao Paulo, Brazil
    Virology 340:95-104. 2005
    ....
  52. ncbi request reprint Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study
    Jennifer S Smith
    International Agency for Research on Cancer, Lyon, France
    Int J Cancer 111:431-9. 2004
    ..0; 95% CI = 0.53-1.9) in HPV DNA-positive women. An association of C. trachomatis with squamous cell ICC was found among all cases and control women with or without adjustment for HPV...
  53. ncbi request reprint Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
    Nathaniel Rothman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Lancet Oncol 7:27-38. 2006
    ..We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International Lymphoma Epidemiology Consortium (InterLymph)...
  54. ncbi request reprint Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer
    Eduardo L Franco
    Division of Cancer Epidemiology, Departments of Oncology and Epidemiology and Biostatistics, McGill University, 546 Pine Avenue West, Montreal, Quebec, Canada
    Vaccine 24:S3/242-9. 2006
    ..The field of HPV and cervical cancer prevention has never been so multi-disciplinary. A new era has begun and the challenges are many...
  55. ncbi request reprint Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts
    Thomas C Wright
    Department of Pathology, Columbia University, 630 W 168th Street, NY 10032, USA
    Vaccine 24:S3/251-61. 2006
    ..In this summary, we summarize the opinions of this expert group on how these advances can be introduced to provide the maximum benefit to women and to reduce the global burden of cervical cancer...
  56. ncbi request reprint [Assessment of HPV detection assays for use in cervical cancer screening programs]
    M Paz Cañadas
    Departamento de Biologia Molecular, Laboratorio de Análisis, General Lab, Barcelona, Espana
    Salud Publica Mex 48:373-8. 2006
    ..The different techniques for detection of this cancer need to be contrasted and validated for use in population screening...
  57. ncbi request reprint Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study
    Silvia Franceschi
    International Agency for Research on Cancer, Lyon, France
    Sex Transm Dis 34:563-9. 2007
    ..Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas...
  58. ncbi request reprint HPV and circumcision: a biased, inaccurate and misleading meta-analysis
    Xavier Castellsague
    J Infect 55:91-3; author reply 93-6. 2007
  59. ncbi request reprint The male role in cervical cancer
    Xavier Castellsague
    Institut Catala d Oncologia, Servel d Epidemiologia I Registre del Càncer, Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Salud Publica Mex 45:S345-53. 2003
    ..More research is needed to better understand the natural history and epidemiology of HPV infections in men. This paper is available too at: http://www.insp.mx/salud/index.html...
  60. ncbi request reprint Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
    Jorma Paavonen
    University of Helsinki, Department of Obstetrics and Gynaecology, Helsinki, Finland
    Lancet 369:2161-70. 2007
    ....
  61. pmc Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions
    Maxime J J Fleury
    INSERM U618, Tours, France
    Clin Vaccine Immunol 15:172-5. 2008
    ..Neutralizing antibodies were detected in 78% of subjects with a positive enzyme-linked immunosorbent assay...
  62. ncbi request reprint Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study
    Martyn Plummer
    Unit of Field and Intervention Studies, International Agency for Research on Cancer, 150 cours Albert Thomas, F 69372 Lyon, France
    Cancer Causes Control 14:805-14. 2003
    ..This analysis is part of a series of analyses of cofactors of HPV in the aetiology of cervical cancer...
  63. ncbi request reprint Primary liver cancer: worldwide incidence and trends
    F Xavier Bosch
    Epidemiology and Cancer Registration Unit, IDIBELL Institut Català d Oncologia, Avda Gran Via s n, Km 2 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Gastroenterology 127:S5-S16. 2004
    ..Primary liver cancer is the first human cancer largely amenable to prevention using hepatitis B virus vaccines and screening of blood and blood products for hepatitis B and C viruses...